RF360 high-resolution system for ADME assays

Monday, 07 June, 2010 | Supplied by: Agilent Technologies Australia Pty Ltd


Biocius Life Sciences and Agilent Technologies have released the RF360 high-resolution system for high-throughput screening of in-vitro ADME assays.

Combining the accurate mass capabilities of Agilent’s time-of-flight mass spectrometers and the sample processing speed of RapidFire technology, the instrument eliminates the method development bottleneck in drug discovery.

RapidFire technology combined with TOF mass spectrometers enables a range of ADME assays, including drug-drug interaction, metabolic stability, Caco, PAMPA and others.

When performing such assays with the system, a prior knowledge of the test compound is not required, as data is acquired in full scan TOF-MS mode.

Post acquisition, the relevant data is extracted using RapidFire software, eliminating the time-consuming and labour-intensive steps of LC/MS method development and batch analysis.

Online: www.agilent.com
Phone: 03 9566 1117
Related Products

Mercodia Insulin MBeads Assay

The assay is designed to offer high accuracy by specifically measuring human insulin while...

Waters BD FACSDiscover A7 Cell Analyzer

The BD FACSDiscover A7 Cell Analyzer combines high spectral resolution and sensitivity with...

Lumiprobe CytoTracer fluorescent cell dyes

The dyes rapidly penetrate cells, form intracellular membrane-impermeable products, and deliver...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd